EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect of Boswellia serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers—A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Trial

Sascha Hammer iD, Marco Reiser, Mathias Bader iD, Jakob Pannold iD, Angelika Moser iD, Maximilian Niederer, Anselm Johannes Schlemmer, Sebastian Labenbacher iD, Kordula Lang-Illeviech, Helmar Bornemann-Cimenti iD

Nutrients · 06.06.2026 · 18 (12) · 1839

DOI: 10.3390/nu18121839 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 06.06.2026. Verfasst von Sascha Hammer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine 1, Medical University of Graz, 8010 Graz, Austria. Hauptthemen laut MEDLINE: Boswellia, Plant Extracts, Analgesics, Pain. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kulturamt der Stadt Graz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Boswellia serrata has traditionally been used in Ayurvedic medicine for its anti-inflammatory and antioxidant properties. Although several studies support clinical analgesic efficacy, the underlying mechanisms have not been investigated in human experimental pain models. This randomized, double-blind, placebo-controlled, crossover pilot trial aimed to examine the mode of action of Boswellia serrata to differentiate between its peripheral and central effects. This exploratory pilot study was designed to generate preliminary effect size estimates and assess functional pain-processing outcomes, rather than to provide definitive evidence of clinical efficacy.

Methods

Twelve healthy volunteers were recruited and received either 300 mg of Boswellia serrata extract or a visually identical placebo twice daily for 28 days, separated by a 4-week washout period. Pain and sensitization were induced using a topical capsaicin model. Outcomes included spontaneous pain intensity, mechanical allodynia, pinprick hyperalgesia, thermal thresholds, and conditioned pain modulation, alongside psychological assessments of mood, anxiety, sleep, and structured adverse-event monitoring.

Results

Results showed no significant difference in the primary endpoint of spontaneous pain intensity between Boswellia and placebo (VAS 43 ± 21 vs. 47 ± 17; d = 0.18; p = 0.539).

Conclusions

While Boswellia serrata did not significantly reduce acute peak pain in this model, the observed trends suggest a potential multi-level modulatory influence on nociceptive processing and endogenous pain inhibition. These findings warrant larger clinical trials to further elucidate its therapeutic potential, particularly in populations with impaired pain modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BoswelliaPlant ExtractsAnalgesicsPainCentral Nervous System SensitizationHumansDouble-Blind MethodPilot ProjectsCross-Over StudiesMaleAdultFemalePain MeasurementYoung AdultHealthy VolunteersPain ThresholdHyperalgesia

Stichwörter der Autor:innen

Boswellia serratacapsaicin modelcentral sensitizationconditioned pain modulationhyperalgesiaquantitative sensory testing

Substanzen

Plant ExtractsAnalgesics

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care Medicine 1, Medical University of Graz, 8010 Graz, Austria.
  • Department of Anesthesiology and Intensive Care Medicine 2, Medical University of Graz, 8010 Graz, Austria.
  • Department of General Radiology, Medical University of Graz, 8010 Graz, Austria.
  • Department of Anesthesiology and Intensive Care Medicine, LKH Güssing, 7540 Güssing, Austria.

ORCID-Profile: Sascha Hammer, Mathias Bader, Jakob Pannold, Angelika Moser, Sebastian Labenbacher, Helmar Bornemann-Cimenti

Förderung

  • Kulturamt der Stadt Graz

Zitieren

APA

Hammer, S., Reiser, M., Bader, M., Pannold, J., Moser, A., Niederer, M., Schlemmer, A. J., Labenbacher, S., Lang-Illeviech, K., & Bornemann-Cimenti, H. (2026). Effect of Boswellia serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers—A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Trial. Nutrients, 18(12), 1839. https://doi.org/10.3390/nu18121839

Vancouver

Hammer S, Reiser M, Bader M, Pannold J, Moser A, Niederer M, et al. Effect of Boswellia serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers—A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Trial. Nutrients. 2026;18(12):1839. doi:10.3390/nu18121839

BibTeX
@article{Hammer2026,
  author = {Hammer, Sascha and Reiser, Marco and Bader, Mathias and Pannold, Jakob and Moser, Angelika and Niederer, Maximilian and Schlemmer, Anselm Johannes and Labenbacher, Sebastian and Lang-Illeviech, Kordula and Bornemann-Cimenti, Helmar},
  title = {Effect of Boswellia serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers—A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Trial},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1839},
  doi = {10.3390/nu18121839}
}
Kostenlos starten →